• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.

作者信息

Szarpak Lukasz, Szwed Piotr, Gasecka Aleksandra, Rafique Zubaid, Pruc Michal, Filipiak Krzysztof J, Jaguszewski Milosz J

机构信息

Maria Sklodowska-Curie Medical Academy, Warsaw, 03-411, Poland.

Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.

出版信息

ESC Heart Fail. 2022 Jun;9(3):2049-2050. doi: 10.1002/ehf2.13812. Epub 2022 Apr 5.

DOI:10.1002/ehf2.13812
PMID:35384369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065811/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd78/9065811/014e21984d93/EHF2-9-2049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd78/9065811/014e21984d93/EHF2-9-2049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd78/9065811/014e21984d93/EHF2-9-2049-g001.jpg

相似文献

1
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.米力农或多巴酚丁胺用于心力衰竭患者：荟萃分析证据
ESC Heart Fail. 2022 Jun;9(3):2049-2050. doi: 10.1002/ehf2.13812. Epub 2022 Apr 5.
2
A bridge for the 21st century in heart transplantation?
Am Heart J. 2003 Feb;145(2):198-9. doi: 10.1067/mhj.2003.51.
3
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.急性失代偿性心力衰竭患者住院期间使用多巴酚丁胺与米力农对院外死亡率的影响。
Pharmacotherapy. 2017 Jun;37(6):662-672. doi: 10.1002/phar.1939.
4
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.比较急性失代偿性心力衰竭治疗中的正性肌力药物。
J Cardiovasc Pharmacol. 2020 May;75(5):455-459. doi: 10.1097/FJC.0000000000000811.
5
Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
Can J Anaesth. 2023 Jul;70(7):1272-1274. doi: 10.1007/s12630-023-02482-7. Epub 2023 May 9.
6
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.等待心脏移植的住院患者中多巴酚丁胺与米力农治疗的比较：一项前瞻性随机试验。
Am Heart J. 2003 Feb;145(2):324-9. doi: 10.1067/mhj.2003.50.
7
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.急性失代偿性心力衰竭患者血管活性治疗的相关结局。
Pharmacotherapy. 2006 Aug;26(8):1078-85. doi: 10.1592/phco.26.8.1078.
8
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.比较多巴酚丁胺与米力农在急性失代偿性心力衰竭和心源性休克中的疗效的荟萃分析。
Curr Probl Cardiol. 2023 Aug;48(8):101245. doi: 10.1016/j.cpcardiol.2022.101245. Epub 2022 May 8.
9
Intermittent inotropes for advanced heart failure: inquiring minds want to know.用于晚期心力衰竭的间歇性正性肌力药物：好奇的人想知道答案。
Am Heart J. 1999 Aug;138(2 Pt 1):191-2. doi: 10.1016/s0002-8703(99)70098-0.
10
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.晚期心力衰竭的姑息性正性肌力药：米力农与多巴酚丁胺的结局比较。
J Card Fail. 2022 Dec;28(12):1683-1691. doi: 10.1016/j.cardfail.2022.08.007. Epub 2022 Sep 17.

引用本文的文献

1
Managing Arrhythmias in Cardiogenic Shock: Insights Into Milrinone and Dobutamine Therapy.心源性休克中心律失常的管理：米力农和多巴酚丁胺治疗的见解
Cureus. 2024 Dec 20;16(12):e76089. doi: 10.7759/cureus.76089. eCollection 2024 Dec.
2
Synthesis and Biophysical Characterization of Fingolimod Derivatives as Cardiac Troponin Antagonists.作为心肌肌钙蛋白拮抗剂的芬戈莫德衍生物的合成与生物物理特性研究
ACS Med Chem Lett. 2024 Feb 7;15(3):413-417. doi: 10.1021/acsmedchemlett.3c00511. eCollection 2024 Mar 14.
3
Discovery of a novel cardiac-specific myosin modulator using artificial intelligence-based virtual screening.

本文引用的文献

1
The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.多巴酚丁胺与米力农在脓毒症中的作用：一项大数据、真实世界研究。
Int J Clin Pract. 2021 Nov;75(11):e14689. doi: 10.1111/ijcp.14689. Epub 2021 Sep 7.
2
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.连续门诊静脉内儿茶酚胺治疗的现代时代的生存。
Am J Ther. 2020 Oct 1;28(6):e621-e630. doi: 10.1097/MJT.0000000000001260.
3
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
利用基于人工智能的虚拟筛选发现新型心脏特异性肌球蛋白调节剂。
Nat Commun. 2023 Nov 24;14(1):7692. doi: 10.1038/s41467-023-43538-y.
4
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.米力农治疗急性失代偿性心力衰竭导致的心源性休克的死亡率和血液动力学改善。
ESC Heart Fail. 2023 Aug;10(4):2577-2587. doi: 10.1002/ehf2.14379. Epub 2023 Jun 15.
5
The Mortality Benefit of Milrinone as a Continuous Outpatient Intravenous Inotrope Therapy in Advanced Heart Failure: A Systemic Review and Meta-Analysis.米力农作为晚期心力衰竭门诊持续静脉注射正性肌力药物治疗的死亡率获益：一项系统评价和荟萃分析
Int J Heart Fail. 2023 Mar 7;5(2):106-110. doi: 10.36628/ijhf.2022.0034. eCollection 2023 Apr.
6
Discovery of novel cardiac troponin activators using fluorescence polarization-based high throughput screening assays.基于荧光偏振的高通量筛选技术发现新型心肌肌钙蛋白激活剂。
Sci Rep. 2023 Mar 30;13(1):5216. doi: 10.1038/s41598-023-32476-w.
7
The effect of dobutamine on ocular blood flow of healthy adults: A 3D pseudocontinuous aterial spin labelling study.多巴酚丁胺对健康成年人眼部血流的影响：一项三维伪连续动脉自旋标记研究。
Front Physiol. 2022 Nov 29;13:1003915. doi: 10.3389/fphys.2022.1003915. eCollection 2022.
急性失代偿性心力衰竭患者住院期间使用多巴酚丁胺与米力农对院外死亡率的影响。
Pharmacotherapy. 2017 Jun;37(6):662-672. doi: 10.1002/phar.1939.
4
Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database.心力衰竭住院患者的资源利用：来自当代国家医院数据库的见解
Am Heart J. 2008 Jun;155(6):978-985.e1. doi: 10.1016/j.ahj.2008.01.015. Epub 2008 Mar 14.
5
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.急性失代偿性心力衰竭患者血管活性治疗的相关结局。
Pharmacotherapy. 2006 Aug;26(8):1078-85. doi: 10.1592/phco.26.8.1078.
6
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).需要静脉注射血管活性药物的急性失代偿性心力衰竭患者的院内死亡率：来自急性失代偿性心力衰竭国家注册数据库（ADHERE）的分析
J Am Coll Cardiol. 2005 Jul 5;46(1):57-64. doi: 10.1016/j.jacc.2005.03.051.
7
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.等待心脏移植的住院患者中多巴酚丁胺与米力农治疗的比较：一项前瞻性随机试验。
Am Heart J. 2003 Feb;145(2):324-9. doi: 10.1067/mhj.2003.50.
8
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.基于多巴酚丁胺和米力农治疗晚期失代偿性充血性心力衰竭的比较：血流动力学疗效、临床结局及经济影响
Am Heart J. 2001 Dec;142(6):998-1002. doi: 10.1067/mhj.2001.119610.
9
Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.米力农与多巴酚丁胺对心脏手术后患者血流动力学影响的比较。
J Cardiothorac Vasc Anesth. 2001 Jun;15(3):306-15. doi: 10.1053/jcan.2001.23274.